Aft Forsyth & Sober’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,400
| Closed | -$753K | – | 79 |
|
|
2024
Q4 | $753K | Hold |
28,400
| – | – | 0.24% | 71 |
|
|
2024
Q3 | $822K | Hold |
28,400
| – | – | 0.27% | 75 |
|
|
2024
Q2 | $795K | Hold |
28,400
| – | – | 0.27% | 76 |
|
|
2024
Q1 | $788K | Hold |
28,400
| – | – | 0.28% | 78 |
|
|
2023
Q4 | $818K | Hold |
28,400
| – | – | 0.32% | 75 |
|
|
2023
Q3 | $942K | Hold |
28,400
| – | – | 0.4% | 73 |
|
|
2023
Q2 | $1.04M | Hold |
28,400
| – | – | 0.43% | 72 |
|
|
2023
Q1 | $1.16M | Hold |
28,400
| – | – | 0.59% | 57 |
|
|
2022
Q4 | $1.46M | Hold |
28,400
| – | – | 0.66% | 43 |
|
|
2022
Q3 | $1.24M | Hold |
28,400
| – | – | 0.6% | 47 |
|
|
2022
Q2 | $1.49M | Hold |
28,400
| – | – | 0.69% | 38 |
|
|
2022
Q1 | $1.47M | Hold |
28,400
| – | – | 0.58% | 49 |
|
|
2021
Q4 | $1.68M | Hold |
28,400
| – | – | 0.59% | 42 |
|
|
2021
Q3 | $1.22M | Hold |
28,400
| – | – | 0.46% | 60 |
|
|
2021
Q2 | $1.11M | Hold |
28,400
| – | – | 0.42% | 60 |
|
|
2021
Q1 | $1.03M | Buy |
28,400
+16,400
| +137% | +$582K | 0.42% | 59 |
|
|
2020
Q4 | $442K | Buy |
+12,000
| New | +$440K | 0.34% | 58 |
|
|
2020
Q3 | – | Sell |
-1,159
| Closed | -$36K | – | 52 |
|
|
2020
Q2 | $36K | Buy |
+1,159
| New | +$39.4K | 0.26% | 53 |
|
|
2016
Q1 | – | Sell |
-1,159
| Closed | -$36K | – | 35 |
|
|
2015
Q4 | $36K | Hold |
1,159
| – | – | 0.01% | 32 |
|
|
2015
Q3 | $35K | Hold |
1,159
| – | – | 0.01% | 31 |
|
|
2015
Q2 | $37K | Hold |
1,159
| – | – | 0.01% | 31 |
|
|
2015
Q1 | $38K | Hold |
1,159
| – | – | 0.01% | 30 |
|
|
2014
Q4 | $34K | Hold |
1,159
| – | – | 0.01% | 31 |
|
|
2014
Q3 | $33K | Hold |
1,159
| – | – | 0.01% | 30 |
|
|
2014
Q2 | $33K | Hold |
1,159
| – | – | 0.01% | 28 |
|
|
2014
Q1 | $35K | Hold |
1,159
| – | – | 0.02% | 19 |
|
|
2013
Q4 | $34K | Hold |
1,159
| – | – | 0.01% | 29 |
|
|
2013
Q3 | $32K | Hold |
1,159
| – | – | 0.01% | 28 |
|
|
2013
Q2 | $31K | Buy |
+1,159
| New | +$32K | 0.01% | 28 |
|
Other funds holding PFE
TIM
Aft Forsyth & Sober's PFE Position: Q1 2025 in Review
Aft Forsyth & Sober sold out of Pfizer (PFE) in Q1 2025, closing a stake of 28,400 shares — an estimated $753K sold.
Aft Forsyth & Sober first reported a position in PFE in Q2 2013 and held it in 29 quarters. The position peaked at $1.68M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Aft Forsyth & Sober reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Aft Forsyth & Sober sold 28,400 Pfizer shares in Q1 2025, an estimated $753K.
- Aft Forsyth & Sober first reported a position in Pfizer in Q2 2013 and held it in 29 quarters.
- Aft Forsyth & Sober's Pfizer position peaked at $1.68M in Q4 2021.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Aft Forsyth & Sober's 13F filing for Q1 2025, filed 12 May 2025.